3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
8
Withdrawn
1
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
11
Endocrine
11
Thoracic
4
Gynecologic
4
Gastrointestinal
2
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Brain Neoplasms
362
Glioblastoma
298
Glioma
239
Neuroblastoma
95
Neoplasms
70
Central Nervous System Neoplasms
62
Astrocytoma
61
Meningioma
59
Breast Neoplasms
51
Lung Neoplasms
46
Carcinoma, Non-Small-Cell Lung
45
Melanoma
39
Sarcoma
34
Medulloblastoma
33
Meningeal Carcinomatosis
32
Recurrence
31
Neoplasm Metastasis
28
Diffuse Intrinsic Pontine Glioma
28
Prostatic Neoplasms
27
Pheochromocytoma
26
Paraganglioma
26
Neurofibromatosis 1
26
Pancreatic Neoplasms
24
Ovarian Neoplasms
24
Oligodendroglioma
22
Ependymoma
21
Head and Neck Neoplasms
20
Spinal Cord Neoplasms
19
Osteosarcoma
19
Kidney Neoplasms
19
Interventions
cobimetinib
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Thyroid Carcinoma, Anaplastic
×
CNS
×
Clear all
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled